EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RBM17 Promotes the Chemoresistance of Oral Squamous Cancer Cells Through Checkpoint Kinase 1

Miyuka Nakahara, Ryosuke Arai iD, Isao Tokuoka iD, Kazuhiro Fukumura iD, Akila Mayeda iD, Masakazu Yashiro iD, Hirokazu Nakahara

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26073127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Miyuka Nakahara und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Mouth Neoplasms, RNA-Binding Proteins, Checkpoint Kinase 1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral squamous cell carcinoma (OSCC) is one of the most common types of cancer in the head and neck region. In advanced stages of OSCC, chemotherapy is commonly used for treatment, despite some cancer cells having low sensitivity to anticancer drugs. We focused on RBM17/SPF45 as an essential drug-sensitizing factor in the context of malignant cells acquiring chemoresistance. Here, we demonstrate how RBM17 affects anticancer drug resistance in OSCC and we suggest the possible mechanism underlying its effects. After exposing oral cancer cell lines to fluorouracil (5-FU) and cisplatin, but not paclitaxel, the gene and protein expression of RBM17 increased. We found that siRNA-mediated RBM17-knockdown of the cell lines gained a significantly higher sensitivity to 5-FU, which was remarkably followed by a decrease in the expression of checkpoint kinase 1 (CHEK1) protein, whereas treatment with a CHEK1 inhibitor did not affect RBM17 protein expression in the oral cancer cell lines. These results indicate that RBM17 is a factor involved in the development of resistance to cytotoxic chemotherapy. We propose the underlying mechanism that RBM17 promotes CHEK1 protein expression in the ATM/ATR pathway, triggering the development of chemoresistance in cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmMouth NeoplasmsRNA-Binding ProteinsCheckpoint Kinase 1Carcinoma, Squamous CellHumansCell Line, TumorGene Expression Regulation, NeoplasticFluorouracilCisplatinAntineoplastic Agents

Stichwörter der Autor:innen

Chk1RBM17/SPF45chemoresistancechemotherapyoral squamous cell carcinoma

Substanzen

RNA-Binding ProteinsCheckpoint Kinase 1FluorouracilCHEK1 protein, humanCisplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
  • Department of Oral and Maxillofacial Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.
  • Oncology Innovation Center, Fujita Health University, Toyoake 470-1192, Japan.
  • xFOREST Therapuetics, Co., Ltd., Kyoto 602-0841, Japan.
  • Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.

ORCID-Profile: Ryosuke Arai, Isao Tokuoka, Kazuhiro Fukumura, Akila Mayeda, Masakazu Yashiro

Zitieren

APA

Nakahara, M., Arai, R., Tokuoka, I., Fukumura, K., Mayeda, A., Yashiro, M., & Nakahara, H. (2025). RBM17 Promotes the Chemoresistance of Oral Squamous Cancer Cells Through Checkpoint Kinase 1. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073127

Vancouver

Nakahara M, Arai R, Tokuoka I, Fukumura K, Mayeda A, Yashiro M, et al. RBM17 Promotes the Chemoresistance of Oral Squamous Cancer Cells Through Checkpoint Kinase 1. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073127

BibTeX
@article{Nakahara2025,
  author = {Nakahara, Miyuka and Arai, Ryosuke and Tokuoka, Isao and Fukumura, Kazuhiro and Mayeda, Akila and Yashiro, Masakazu and Nakahara, Hirokazu},
  title = {RBM17 Promotes the Chemoresistance of Oral Squamous Cancer Cells Through Checkpoint Kinase 1},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26073127}
}
Kostenlos starten →